Hinge Health’s Post

Advancing Cardiac Surgery: Identifying Predictors of Aortic Expansion in TEVAR Patients 🔍 A pivotal study by Zhiqiang Dong, He Yang, Gang Li, Xinyang Xu, Hong Liu, Jiaxi Gu, Minghui Liu, MD, Weidong Gu, Yongfeng Shao, Buqing Ni, "Preoperative Predictors of Late Aortic Expansion in Acute Type B Aortic Dissection Treated with TEVAR," published in a leading medical journal, brings new insights to cardiac care. 📊 Study Insights: Analysis of patients treated with Thoracic Endovascular Aortic Repair (TEVAR) for type B aortic dissection. Identification of key preoperative factors such as partial thrombosis and aortic diameter linked to late aortic expansion. 🎯 Clinical Impact: This study underlines the importance of detailed preoperative assessment in patients undergoing TEVAR, potentially guiding more tailored and effective treatment strategies. 🎓 The research contributes significantly to our understanding of aortic dissection treatments and opens doors for enhancing patient care in cardiac surgery. Earn 1.0 CME credit by exploring these critical findings. https://ow.ly/515X50QoxMp #CardiacSurgery #MedicalResearch #TEVAR #AorticDissection #CME

Today on BackTable MSK: Cervical and thoracic epidural steroid injections (ESIs) can offer relief for patients with chronic pain; however, these procedures can carry serious risks. Providers should be well-trained to anticipate and mitigate these risks before treating patients with ESIs. In this Part II of our discussion on ESI's, Dr. Christopher Beck and I dive into various techniques and considerations for performing cervical and thoracic ESIs. We discuss the importance of trajectory and level aiming, the differences between interlaminar and transforaminal approaches, and the nuances of cervical and thoracic ESI procedures. The episode also covers patient positioning and potential complications. Listen below to learn more! #msk #musculoskeletal #msk56 #collaborativelearning #radiology #mskradiology #painmanagement #podcast Thank you for supporting this episode Stryker Interventional Spine! Alexa Levey J. Michael Barraza Jr. Sabeen Dhand J. David Prologo MD, FSIR, ABOM-D Douglas Beall Dana Dunleavy Dan Nguyen MD Luigi Manfre Aparna Baheti MD Edward Yoon William Morrison, MD FACR Jason Cox, MD Alok Sharan John S. Michels, MD Stephen Hunt, MTR, MD, PhD, FSIR https://lnkd.in/gVk6iTGW

"You can assess the polyp or the tumour during your index colonoscopy and then you can go ahead and treat this patient, if they're suitable, at the same time. So it doesn't often involve any additional procedures to be undertaken."   We invited Mr Amyn Haji, international expert in interventional endoscopy for 11 years, to talk about his experiences in Electroporation in Endoscopy. In this video, he explains why he started using the EndoVE® device.   EndoVE® is designed for the safe application of pulsed electrical fields to gastrointestinal tissue. It can be used to treat solid tumours within the GI tract including oesophageal, gastric and colorectal cancers and potentially halt and reduce tumour growth allowing a wider range of treatment options. Watch the full interview with many other insights on Electroporation in Endoscopy here: 🔗https://lnkd.in/eu72V6mt   Mirai Medical #expertspeaking #electroporation #endoscopy #innovations #partoftheduomedgroup

【Primary Left Atrial Intimal Sarcoma Disguised as Functional Mitral Stenosis: A Case Study】 Full article: https://lnkd.in/gVvHmvNV (Authored by Zachary Visinoni, et al., from Sutter Roseville Medical Center (USA), etc.) Primary cardiac #intimal_sarcoma presents several challenges to clinicians and surgeons due to its location, propensity for distant metastasis, and difficulty in achieving complete resection. This paper presents a case report of a patient who presented clinically with heart failure from functional #mitral_stenosis and regurgitation. The etiology of mitral stenosis in the patient was unusual: primary left atrial (LA) intimal sarcoma. #Cardiac_Tumor #Atrial_Mass

🔍🌸 𝐄𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐎𝐯𝐚𝐫𝐢𝐚𝐧 𝐂𝐲𝐬𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐚𝐧𝐝 𝐓𝐫𝐞𝐧𝐝𝐬 🏥💡 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/gd9WJD3J 📊 Market Overview: The Ovarian Cysts Market encompasses a range of diagnostic modalities, treatment options, and supportive care measures aimed at addressing the diverse needs of women with ovarian cysts. Ovarian cysts vary in size, composition, and clinical significance, ranging from functional cysts that resolve spontaneously to complex cystic masses requiring medical intervention. Diagnostic imaging techniques, such as ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT), play a crucial role in detecting, characterizing, and monitoring ovarian cysts, guiding treatment decisions and optimizing patient care. 💼🔬 🌟 Key Trends and Insights: Early Detection and Diagnosis: Early detection and accurate diagnosis of ovarian cysts are essential for timely intervention and optimal patient outcomes. Transvaginal ultrasound is the primary imaging modality used to evaluate ovarian cysts, providing detailed anatomical information and assessing cyst morphology, size, and vascularity. Advanced imaging techniques, such as MRI and CT, offer complementary information and help differentiate benign cysts from malignant ovarian tumors, facilitating appropriate treatment planning and risk stratification. Minimally Invasive Interventions: Minimally invasive surgical techniques, such as laparoscopy and robotic-assisted surgery, have revolutionized the management of ovarian cysts, offering patients less invasive treatment options, shorter recovery times, and reduced postoperative complications. Laparoscopic cystectomy, the removal of ovarian cysts through small incisions in the abdomen, preserves ovarian function and fertility while minimizing scarring and intraoperative risks. In cases of complex or suspicious cystic masses, laparoscopic or robotic-assisted ovarian staging may be performed to assess disease extent and facilitate comprehensive surgical management. #Company Pfizer Teva Pharmaceuticals Quest Diagnostics Novartis GE Merck Group Boston Scientific Medtronic #Type Functional Cysts Non-Functional Cysts #Application Hospital Clinic Others #WomensHealth #OvarianCysts #MedicalImaging #HealthcareInnovation

🔥🔥 Happy to share pur last paper on impact of different MR mechanism in patients undergoing TAVR #JAHA ✅ Patients with atrial secondary MR have better survival and lowest rate of severe MR post–TAVR ✅ Patients with degenerative leaflet prolapse who experience the worst prognosis and highest rate of residual severe MR post-TAVR 🎯 The challenging dilemma of concomitant AS and MR is even more relevant with the shifting of percutaneous treatment towards younger patients⚖️ ➡️ MR due to leaflet prolapse/flail ⏩⏩ need to address the mitral valve pathology, either surgically or by transcatheter options. ➡️ atrial MR may contribute to tip the balance between surgery and percutaneous treatment of AS towards the latter, considering the good prognosis of this subgroup Full text at https://lnkd.in/dsQXqd4W #echofirst #MR #TAVR #JAHA #AHA Annamaria Tavernese Alberto Preda Francesco Ancona Giacomo Ingallina Stefano Stella Eustachio Agricola

💡 What is #cTnI? 👉 Cardiac Troponin I (cTnI) is a protein found in #cardiac muscle with a molecular weight of 22.5 kDa. Troponin I is part of a three subunit complex comprising of #TroponinT and Troponin C. Along with tropomyosin, this structural complex forms the main component that regulates the calcium sensitive ATPase activity of actomyosin in striated skeletal and cardiac muscle. After cardiac injury occurs, #TroponinI is released into the blood 4-6 hours after the onset of pain. The release pattern of cTnI is similar to CK-MB, but while #CKMB levels return to normal after 72 hours, Troponin I remains elevated for 6-10 days, thus providing for a longer window of #detection for cardiac injury.  The high specificity of cTnI measurements for the identification of myocardial damage has been demonstrated in conditions such as the perioperative period, after marathon runs, and blunt chest trauma. cTnI release has also been documented in cardiac conditions other than acute myocardial infarction (#AMI) such as unstable angina, congestive #heart failure, and ischemic damage due to coronary artery bypass surgery. Because of its high specificity and sensitivity in the myocardial tissue, Troponin I has recently become the most preferred biomarker for myocardial infarction. 👉 The #CardiacTroponinI (cTnI) Rapid Test (Whole Blood/Serum/Plasma) is a simple test that utilizes a combination of anti-cTnI antibody coated particles and capture reagent to detect cTnI in whole blood, serum or plasma.  The minimum detection level is 0.5 ng/mL. 🔎 More information：https://lnkd.in/gRD-2rD9 #medicaltreatment #MEDLAB #MEDICA #healthy #medical #IVD #diagnosis #RapidTest

Unlock the diagnostic power of MRI with our enlightening infographic on '5 Key Conditions Detected by Abdominal MRI.' Here's what you need to know: Cancers and Tumors: MRI can detect tumors with a high degree of accuracy, significantly improving treatment success rates. For instance, early detection of liver cancer through MRI has a potential 5-year survival rate increase of up to 70%. Inflammatory Diseases: Conditions like Crohn's disease, often elusive in early stages, can be accurately identified with MRI, leading to timely and effective treatment. Liver Disorders: Early MRI detection of liver cirrhosis can lead to interventions that may reduce liver failure risks by up to 30%. Pancreatic Conditions: Detecting pancreatic abnormalities early through MRI can increase the success rate of surgical interventions by over 40%. Gastrointestinal Obstructions: Timely MRI identification of obstructions can prevent complications, reducing emergency surgery rates by up to 50%. Discover how advanced MRI technology is transforming the landscape of abdominal health diagnostics and improving patient outcomes. #earlydetection

#ABCWIN2024 #INReporters 𝗧𝘂𝗲𝘀𝗱𝗮𝘆 𝗺𝗼𝗿𝗻𝗶𝗻𝗴 𝘀𝗲𝘀𝘀𝗶𝗼𝗻 𝘈𝘝𝘔 𝘵𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵 👉 Dr. Cervo reported his experience using large catheters to selectively study the feeders of bAVMs. It is a useful tool to better understand the angioarchitecture of the arteriovenous shunt & the contribution of every single feeder before starting embolization. It can be combined with 3D reconstructions & cone beam CT. 👉 Dr. Spelle presented the results of CHOICE study (European, prospective, observational, multicentre) assessing bAVM treatment with SQUID embolic agent by embolization alone or in combination with other treatments in patient with previously untreated bAVM followed for 1 year. ➡️ 109 patients were enrolled (mean age 46.3, 50.5% male) ➡️ bAVM were located in the left side in 55% of the cases, in the supratentorial region in 76.1% & in the eloquent site in 57.8%. ➡️ most bAVMs were Spetzler-Martin grade I-II (67%) ➡️ mean bAVM diameter was 2.3±1.5 & the nidus was small (<3mm) in 78.9% of the cases. 80.7 % of the patients had a baseline mRS score of 0-2. ➡️ most patients underwent embolization alone (80.7%) & 19.3% received a complementary treatment (85.7% underwent neurosurgery and 14.3% radiotherapy). ➡️ the morbi-mortality related to SQUID or the procedure was 6.4% at 3/6 months and decreased to 4.9% at 1 year. No mortality related to SQUID or the procedure occurred. At the 3/6-month visit, 63.2% of patients treated with embolization alone achieved a complete occlusion.  👉 Pr. Chapot presented an imaging modality named 6D by realizing a fusion of 2 3D volumes while attributing a different colour to each 3D volume (using the Siemens Icono Biplane). 𝟲𝗗 = 𝟯𝗗 +𝟯𝗗. It can even consist in 3D global + 3D selective. It allows analysis - of the entire AVM - of arterial anastomosis to consider antegrade access to retrograde feeders - of arterial supply to primary veins - of a single feeder of a small AVM. It takes time to analyse all images but Pr. Chapot emphazises that “AVM is all about understanding”. Then followed a discussion about other technics such as 4D. 👉 Very controversial communication has followed on off-label embolization with Squid through a Magic. An engineer of Balt company reminded us the best practice. First Magic is not DSMO compatible with the risk of melting the catheter leading to a rupture & systemic diffusion of chemical compounds, second Magic shouldn’t be used with 1cc syringe due to the potential high pressure. Magic is guaranty to be used with a 2.5cc syringe minimum. 𝙋𝙡𝙚𝙖𝙨𝙚 𝙛𝙤𝙧 𝙩𝙝𝙚 𝙨𝙖𝙛𝙚𝙩𝙮 𝙤𝙛 𝙮𝙤𝙪𝙧 𝙥𝙖𝙩𝙞𝙚𝙣𝙩 𝙠𝙚𝙚𝙥 𝙩𝙝𝙖𝙩 𝙞𝙣 𝙢𝙞𝙣𝙙 ! 💡 𝐒𝐭𝐚𝐲 𝐭𝐮𝐧𝐞𝐝 𝘋𝘳. 𝘈𝘯𝘯𝘦-𝘊𝘩𝘳𝘪𝘴𝘵𝘪𝘯𝘦 𝘑𝘢𝘯𝘶𝘦𝘭 & P𝘳. 𝘑𝘦𝘢𝘯-𝘊𝘩𝘳𝘪𝘴𝘵𝘰𝘱𝘩𝘦 𝘎𝘦𝘯𝘵𝘳𝘪𝘤 Content dedicated for an international audience

https://lnkd.in/dV26Mxm3 Multimodal Evaluation of Carotid Stenosis, CAS vs CEA ECR 2022, EPOS™ 🎅🚬 Male smokers older than 70 years with DM and dyslipidemia are at high risk 💣 for atherosclerotic carotid artery disease [1-3]. 🧠 Hemispheric TIA is the most common initial event [4]. ✅ DUS is a 1st line choice, safe & low-cost technique with high availability that shortens time to treatment [5].  ✅ CTA cross-sectional area reduction method according to NASCET is the most accurate in stenosis grading [6]. ✅ Between CTA diameter-based methods we support ECST, because NASCET underestimates stenosis [7]. ✅ CAS is a safe technique, less invasive than CEA, can replace endarterectomy in appropriately selected patients [8, 9]. 📚 References (in the link) #carotid #stenosis #doppler #ultrasound #cta #mra #dsa #stent #vascular #surgery #education #radiology